Baxdrostat and its Impurities

Baxdrostat's mechanism of action is rooted in its ability to inhibit the enzyme aldosterone synthase (CYP11B2). it is a novel, investigational drug that is currently in clinical trials for the treatment of hypertension. Reference standards of Baxdrostat API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 3 results for Baxdrostat Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 02 2820000

Baxdrostat

Baxdrostat

  • Catalogue No.:PA 02 2820000

  • CAS :

    1428652-17-8

  • Molecular Formula : C22H25N3O2

  • Molecular Weight : 363.46

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 2821000

4-Bromo-6,7-dihydroisoquinolin-8(5H)-one

4-Bromo-6,7-dihydroisoquinolin-8(5H)-one

  • Catalogue No.:PA 02 2821000

  • CAS :

    1428651-86-8

  • Molecular Formula : C9H8BrNO

  • Molecular Weight : 226.07

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 2821001

1-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinolin-2(1H)-one

1-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinolin-2(1H)-one

  • Catalogue No.:PA 02 2821001

  • CAS :

    1427587-32-3

  • Molecular Formula : C16H22BNO3

  • Molecular Weight : 287.17

Enquire
Details
Periodic Table- Pharmaffiliates

Calculators
Periodic Table- Pharmaffiliates

Contact us

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help
pharmaffiliates